ProductNum | picture | CAS No. | Name and description | Formula | Quick order |
---|---|---|---|---|---|
CL3310 |
|
2728667-27-2 |
Zongertinib (Synonyms: BI 1810631;BI 764532) 98+% |
C29H29N9O2 | |
CL1991B |
|
2805804-54-8 |
CP-547632 TFA 98+% |
C20H24BrF2N5O3S·C2HF3O2 | |
CL2879A |
|
210644-62-5 |
(Z)-Orantinib | (Z)-SU6668 | (Z)-TSU-68 98+% |
C18H18N2O3 | |
CL2509 |
|
1013920-15-4 |
Vorolanib (X-82,CM082) 98+% |
C23H26FN5O3 | |
CL2507A |
|
1218779-75-9 |
Apatinib Mesylate 98+% |
C24H23N5O · CH4O3S | |
CL2507 |
|
811803-05-1 |
Apatinib | Apatinib Free base | YN968D1| Rivoceranib 98+% |
C24H23N5O | |
CL2424 |
|
557795-19-4 |
Sunitinib | Sunitinib Base 99+% |
C22H27FN4O2 | |
CLA1508 |
|
1607793-29-2 |
Anti-Human VEGFAxANGPT2 (Faricimab; RG7716) 95+% |
— | |
CLA1500 |
|
1969309-56-5 |
Anti-Human Her2xHer3 (Zenocutuzumab; MCLA-128; PB4188; R040517) 95+% |
— | |
CLA1339 |
|
1350624-75-7 |
Margetuximab (Anti-ERBB2 / HER2 / CD340) 95+% |
— | |
CLA1267 |
|
1024603-92-6 |
Icrucumab (Anti-VEGFR1 / FLT1) 95+% |
— | |
CLA1179 |
|
934216-54-3 |
Alacizumab (Anti-VEGFR2 / KDR / CD309) 95+% |
— | |
CL2214 |
|
215543-92-3 |
(Z)-3-(4-methyl-2-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid. 98+% |
C17H16N2O3 | |
CLA1033 |
|
1018448-65-1 |
Ado-trastuzumab Emtansine (TDM-1) 95+% |
— | |
CL1631 |
|
288383-20-0 |
Cediranib | ADZ-2171 | NSC-732208 98+% |
C25H27FN4O3 | |
CL1633 |
|
417716-92-8 |
Lenvatinib | E7080 98+% |
C21H19ClN4O4 | |
CL1636 |
|
444731-52-6 |
Pazopanib | GW786034 99+% |
C21H23N7O2S | |
CL1637 |
|
319460-85-0 |
Axitinib | AG-013736 98+% |
C22H18N4OS | |
CL1033 |
|
808118-40-3 |
Roxadustat | FG-4592 98+% |
C19H16N2O5 | |
CLA1025 |
|
380610-27-5 |
Pertuzumab; 2C4 98+% |
— | |